Lingohr Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,734
| Closed | -$769K | – | 62 |
|
|
2024
Q1 | $769K | Buy |
9,734
+1,634
| +20% | +$125K | 1.92% | 19 |
|
|
2023
Q4 | $634K | Hold |
8,100
| – | – | 1.45% | 31 |
|
|
2023
Q3 | $561K | Hold |
8,100
| – | – | 1.45% | 38 |
|
|
2023
Q2 | $555K | Hold |
8,100
| – | – | 1.41% | 32 |
|
|
2023
Q1 | $597K | Buy |
8,100
+3,400
| +72% | +$285K | 1.52% | 17 |
|
|
2022
Q4 | $435K | Hold |
4,700
| – | – | 1.22% | 35 |
|
|
2022
Q3 | $445K | Hold |
4,700
| – | – | 1.22% | 34 |
|
|
2022
Q2 | $450K | Buy |
+4,700
| New | +$459K | 1.2% | 38 |
|
|
2022
Q1 | – | Sell |
-6,237
| Closed | -$647K | – | 90 |
|
|
2021
Q4 | $647K | Sell |
6,237
-81
| -1% | -$7.49K | 1.62% | 6 |
|
|
2021
Q3 | $536K | Hold |
6,318
| – | – | 1.43% | 15 |
|
|
2021
Q2 | $527K | Hold |
6,318
| – | – | 1.33% | 17 |
|
|
2021
Q1 | $475K | Buy |
6,318
+1,000
| +19% | +$72.8K | 1.19% | 40 |
|
|
2020
Q4 | $363K | Hold |
5,318
| – | – | 1.05% | 55 |
|
|
2020
Q3 | $311K | Buy |
5,318
+700
| +15% | +$43.6K | 1.1% | 11 |
|
|
2020
Q2 | $291K | Buy |
+4,618
| New | +$291K | 1.18% | 51 |
|
|
2019
Q2 | – | Sell |
-13,716
| Closed | -$739K | – | 121 |
|
|
2019
Q1 | $739K | Hold |
13,716
| – | – | 0.76% | 64 |
|
|
2018
Q4 | $894K | Sell |
13,716
-15,432
| -53% | -$1.15M | 0.96% | 28 |
|
|
2018
Q3 | $2.29M | Sell |
29,148
-3,130
| -10% | -$224K | 1.55% | 7 |
|
|
2018
Q2 | $2.08M | Sell |
32,278
-2,231
| -6% | -$147K | 1.3% | 9 |
|
|
2018
Q1 | $2.15M | Buy |
34,509
+4,279
| +14% | +$307K | 1.34% | 11 |
|
|
2017
Q4 | $2.19M | Buy |
30,230
+1,430
| +5% | +$104K | 1.15% | 17 |
|
|
2017
Q3 | $1.97M | Buy |
28,800
+6,400
| +29% | +$506K | 1.01% | 18 |
|
|
2017
Q2 | $1.76M | Buy |
22,400
+1,900
| +9% | +$150K | 1.02% | 15 |
|
|
2017
Q1 | $1.61M | Buy |
20,500
+9,400
| +85% | +$750K | 0.88% | 16 |
|
|
2016
Q4 | $876K | Buy |
+11,100
| New | +$898K | 0.54% | 66 |
|
|
2015
Q1 | – | Sell |
-26,530
| Closed | -$2M | – | 104 |
|
|
2014
Q4 | $2M | Sell |
26,530
-24,130
| -48% | -$2.13M | 0.5% | 81 |
|
|
2014
Q3 | $4.03M | Buy |
50,660
+24,130
| +91% | +$1.9M | 0.58% | 68 |
|
|
2014
Q2 | $2M | Sell |
26,530
-36,800
| -58% | -$2.78M | 0.5% | 81 |
|
|
2014
Q1 | $4.74M | Sell |
63,330
-37,900
| -37% | -$2.68M | 0.97% | 46 |
|
|
2013
Q4 | $7.25M | Sell |
101,230
-34,866
| -26% | -$2.24M | 1.46% | 26 |
|
|
2013
Q3 | $7.72M | Buy |
136,096
+44,600
| +49% | +$2.66M | 1.3% | 28 |
|
|
2013
Q2 | $5.23M | Buy |
+91,496
| New | +$5.3M | 0.97% | 42 |
|
Other funds holding CVS
Lingohr Asset Management's CVS Position: Q2 2024 in Review
Lingohr Asset Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 9,734 shares — an estimated $769K sold.
Lingohr Asset Management first reported a position in CVS in Q2 2013 and held it in 32 quarters. The position peaked at $7.72M in Q3 2013. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Lingohr Asset Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Lingohr Asset Management sold 9,734 CVS Health shares in Q2 2024, an estimated $769K.
- Lingohr Asset Management first reported a position in CVS Health in Q2 2013 and held it in 32 quarters.
- Lingohr Asset Management's CVS Health position peaked at $7.72M in Q3 2013.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Lingohr Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.